Stock AMP AMPLIFON S.P.A.
Add to a list
To use this feature you must be a member
Log inSign up

Amplifon S.p.A. Stock

Equities

AMP

IT0004056880

Medical Equipment, Supplies & Distribution

Market Closed - Borsa Italiana
Other stock markets
 11:44:59 2024-12-10 am EST 		5-day change 1st Jan Change
24.87 EUR 0.00% Intraday chart for Amplifon S.p.A. +2.77% -20.64%
Dec. 09 Terna, Poste, Eni and Snam top in EU for digital transparency AN
Dec. 03 Italian stock market maglia rosa; Mib at 33,900 AN

Valuation: Amplifon S.p.A.

Capitalization 5.61B 5.91B 5.21B 4.62B 8.37B 501B 9.26B 64.73B 23.87B 206B 22.18B 21.68B 897B P/E ratio 2024 *
33.9x
P/E ratio 2025 * 27.3x
Enterprise value 6.75B 7.11B 6.27B 5.56B 10.08B 603B 11.14B 77.92B 28.73B 248B 26.7B 26.1B 1,080B EV / Sales 2024 *
2.8x
EV / Sales 2025 * 2.53x
Free-Float
-
Yield 2024 *
1.18%
Yield 2025 * 1.45%
More valuation ratios * Estimated data

Chart: Amplifon S.p.A.

Dynamic Chart

Latest news: Amplifon S.p.A.

Terna, Poste, Eni and Snam top in EU for digital transparency Dec. 09 AN
Italian stock market maglia rosa; Mib at 33,900 Dec. 03 AN
Stock markets in the green; Amplifon leads the rises on the Mib. Dec. 03 AN
Declines expected in opening; focus on Stellantis Dec. 02 AN
Italian acquisitions grow in the heart of Europe Dec. 02 AN
Mib closes up; TIM down after Inwit exit Nov. 29 AN
Europeans without momentum, weighs Eurozone inflation Nov. 29 AN
Mib in red; up MPS and Amplifon, down Generali Nov. 29 AN
Launch costs hit Sonova's profit, as it bets on new product with AI tech Nov. 19 RE
AMPLIFON : Mixed Q3; 2024 profitability guidance again trimmed Oct. 31Alphavalue
Mib down; down STM after accounts. Oct. 31 AN
Milan stock market negative at start, wait for macro data, Stellantis rises, Amplifon down Oct. 31 RE
Stock markets still down ahead of Italy and Eurozone macro Oct. 31 AN
More news

Last Transcript: Amplifon S.p.A.

Logo Amplifon S.p.A.
Amplifon S.p.A., Nine Months 2024 Earnings Call, Oct 30, 2024
Oct. 30
More transcripts

Analysts' recommendations: Amplifon S.p.A.

AMPLIFON : Mixed Q3; 2024 profitability guidance again trimmed Oct. 31Alphavalue
AMPLIFON : Incorporating the moderation in profitability guidance, although long-term attractiveness is intact Sep. 10Alphavalue
AMPLIFON : Q2 miss; profitability guidance moderated Jul. 31Alphavalue
Oddo BHF Downgrades Amplifon to Neutral, Lowers PT Jul. 16 MT
AlphaValue/Baader Europe Upgrades Amplifon to Buy from Add, Lifts PT Jul. 08 MT
More recommendations

Press Releases: Amplifon S.p.A.

Amplifon S p A : Interim Financial Report as at 30 September 2024 Nov. 07 PU
Amplifon Hearing Health Care Achieves HITRUST r2 Certification Oct. 31 BU
Amplifon S p A : Strong revenue growth at 1.75 billion euros in the first nine months of 2024 ( 8%) and EBITDA at 412.2 million euros ( 6.9%) with margin increasing at 23.6% ( 10 bps) Oct. 30 PU
Amplifon S p A : Q3 & 9M 2024 results presentation Oct. 28 PU
Amplifon Named One of the 200 “America’s Most Loved Workplaces” by Newsweek Oct. 02 BU
More press releases

News in other languages: Amplifon S.p.A.

Borse : Europa ferma, a Milano solo il risiko bancario in fermento Dec. 10
Terna, Poste, Eni e Snam al top in UE per trasparenza digitale Dec. 09
Borsa : Europa chiude positiva ma guarda a Francia, a Milano (+0,75%) brilla Campari -2- Dec. 04
Borsa italiana maglia rosa; Mib a quota 33.900 Dec. 03
Borse in verde; Amplifon guida i rialzi sul Mib Dec. 03
More news

Quotes and Performance

1 day+0.93%
1 week+3.93%
Current month+3.50%
1 month+2.05%
3 months-12.24%
6 months-26.85%
Current year-20.64%
More quotes

Course Extremes

1 week
24.04
Extreme 24.04
25.19
1 month
22.89
Extreme 22.89
25.23
Current year
22.89
Extreme 22.89
35.14
1 year
22.89
Extreme 22.89
35.14
3 years
22.89
Extreme 22.89
47.59
5 years
14.83
Extreme 14.83
47.59
10 years
4.69
Extreme 4.694
47.59
More quotes

Managers and Directors: Amplifon S.p.A.

Director TitleAgeSince
Enrico Vita CEO
 Chief Executive Officer 55 2015-10-21
Gabriele Galli DFI
 Director of Finance/CFO 55 2017-02-28
Andrea Ciccolini CTO
 Chief Tech/Sci/R&D Officer - 2020-06-30
Manager TitleAgeSince
Susan Carol Holland CHM
 Chairman 68 2010-12-31
Maurizio Costa BRD
 Director/Board Member 76 2007-04-23
Giovanni Tamburi BRD
 Director/Board Member 70 2013-04-16
More insiders

ETFs: Amplifon S.p.A.

Name Weight AuM 1st Jan change Investor Rating
FRANKLIN FTSE ITALY ETF - USD ETF Franklin FTSE Italy ETF - USD
1.32% 5 M€ +12.55%
INDEXIQ FACTORS SUSTAINABLE EMU EQUITY UCITS ETF - EUR ETF IndexIQ Factors Sustainable EMU Equity UCITS ETF - EUR
0.23% 2 M€ +15.94%
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY ETF Nomura NEXT FUNDS International Equity MSCI-KOKUSAI (Yen-Hedged) ETF - JPY
0.19% 20 M€ +16.38% -
More ETFs: Amplifon S.p.A.

Other Medical Equipment, Supplies & Distribution

Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Change 5d. change 1-year change 3-years change Capi. ($)
AMPLIFON S.P.A. Stock Amplifon S.p.A.
+0.93%+3.93%-11.71%-40.27%5.88B
ABBOTT LABORATORIES Stock Abbott Laboratories
+0.52%-1.12%+10.52%-12.85%199B
MEDTRONIC PLC Stock Medtronic plc
-0.45%-3.42%+5.33%-25.91%108B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-0.70%-0.62%-4.67%-9.66%64.48B
HOYA CORPORATION Stock Hoya Corporation
+0.59%+4.40%+22.10%+11.97%46.68B
CENCORA, INC. Stock Cencora, Inc.
-1.46%-5.15%+17.48%+94.77%46.49B
TERUMO CORPORATION Stock Terumo Corporation
-1.79%-1.37%+28.17%+26.43%30.2B
DEXCOM, INC. Stock DexCom, Inc.
+1.28%+0.13%-32.11%-43.29%30.63B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-0.90%-1.05%-6.71%-25.61%23.33B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-0.98%-1.90%-7.59%-13.58%21.79B
Average -0.30%-0.46%+2.08%-3.80% 57.64B
Weighted average by Cap. -0.14%-1.50%+6.40%-4.63%
See all sector performances

Financials

2024 *2025 *
Net sales 2.41B 2.54B 2.24B 1.99B 3.59B 215B 3.98B 27.8B 10.25B 88.34B 9.53B 9.31B 385B 2.63B 2.77B 2.44B 2.16B 3.92B 235B 4.33B 30.31B 11.18B 96.32B 10.39B 10.15B 420B
Net income 160M 169M 149M 132M 239M 14.33B 265M 1.85B 683M 5.88B 634M 620M 25.65B 200M 211M 186M 165M 299M 17.91B 331M 2.31B 853M 7.35B 793M 775M 32.05B
Net Debt 1.14B 1.2B 1.06B 942M 1.71B 102B 1.89B 13.19B 4.86B 41.92B 4.52B 4.42B 183B 1.03B 1.08B 957M 849M 1.54B 92.03B 1.7B 11.88B 4.38B 37.77B 4.07B 3.98B 165B
More financial data * Estimated data

Company Profile

Logo Amplifon S.p.A.
Amplifon S.p.A. is the leading worldwide distributor of auditory devices. The activity is organized around 2 sectors: - hearing aid sales : auditory prostheses and implants (Amplifon, Beter Horen, Miracle Ear and Sonus brands); - services . At the end of 2023, the group has a network of 9,650 outlets distributed between owned stores (5,110), franchise stores (1,240) and other (3,300; including corners). Net sales are distributed geographically as follows: Europe/Middle East/Africa (65.7%), Americas (19%), and Asia/Pacific (15.3%).
Employees
12,715
Sector
Medical Equipment, Supplies & Distribution
Calendar
2025-03-05 - Q4 2024 Earnings Call
More about the company

Quotes

Date Price Change Volume
24-12-10 24.87 € +0.93% 726,551
24-12-09 24.64 € +1.40% 425,662
24-12-06 24.30 € +0.41% 467,565
24-12-05 24.20 € -0.04% 577,803
24-12-04 24.21 € +0.04% 666,558

Real-time Borsa Italiana, December 10, 2024 at 11:44 am EST

More quotes

Income Statement and Estimates

income-statement-evolution-chart AMPLIFON-S-P-A More financial data

Ratings

Trading Rating
Investor Rating
ESG Refinitiv
B+
surperformance-ratings-light-chart AMPLIFON-S-P-AMore Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
24.87EUR
Average target price
32.15EUR
Spread / Average Target
+29.27%
Consensus
Profit revisions
estimates-change-chart AMPLIFON-S-P-A Estimate revisions

Quarterly revenue - Rate of surprise

quality-estimates-chart AMPLIFON-S-P-A Company calendar
  1. Stock Market
  2. Equities
  3. AMP Stock